Inhibitors of haemopoiesis and their potential clinical relevance
- 1 December 1995
- journal article
- Published by Elsevier in Blood Reviews
- Vol. 9 (4) , 226-233
- https://doi.org/10.1016/s0268-960x(95)90014-4
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Requirement of Mip-1α for an Inflammatory Response to Viral InfectionScience, 1995
- Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphomaCancer, 1994
- Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.The Journal of Experimental Medicine, 1994
- Clinical potential for TGF-βThe Lancet, 1994
- Contrasting effects of rh‐MIP‐1α and TGF‐β1on chronic myeloid leukemia progenitors in vitroThe International Journal of Cell Cloning, 1993
- Hemopoietic Stem Cell Inhibitor (SCI/MIP-1∝) Also Inhibits Clonogenic Epidermal Keratinocyte ProliferationJournal of Investigative Dermatology, 1993
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- Identification and characterization of an inhibitor of haemopoietic stem cell proliferationNature, 1990
- Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines.Journal of Clinical Investigation, 1989
- An Inhibitor of Stem Cell Proliferation in Normal Bone MarrowBritish Journal of Haematology, 1976